Difference between revisions of "Part:BBa K917005:Design"

(→‎Design Notes)
(→‎References)
 
(One intermediate revision by the same user not shown)
Line 10: Line 10:
 
===Source===
 
===Source===
  
−
Enterobacter cloacae
+
''Enterobacter cloacae'' genomic DNA
  
 
===References===
 
===References===
 +
Nicklin, C. E., & Bruce, N. C. (1998). Aerobic degradation of 2,4,6-Trinitrotoluene by Enterobacter cloaceae PB2 and by Pentaerythritol tetranitrate reductase. Applied and environmental microbiology , 2864-2868.
 +
 +
Nillius, D., Muller, J., & Muller, N. (2011). Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs. Journal of antimicrobial chemotherapy, 1029-1035.

Latest revision as of 20:32, 1 October 2012

lac promoter plus nitroreductase (nsfI) gene from Enterobacter cloacae


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal AgeI site found at 1189
  • 1000
    COMPATIBLE WITH RFC[1000]


Design Notes

This part includes the native ribosome binding site. The original sequence (http://www.ncbi.nlm.nih.gov/nuccore/M63808.1) had a PstI restriction site however the cloned gene did not have PstI restriction site ( confirmed trough sequencing and restriction digest).

Source

Enterobacter cloacae genomic DNA

References

Nicklin, C. E., & Bruce, N. C. (1998). Aerobic degradation of 2,4,6-Trinitrotoluene by Enterobacter cloaceae PB2 and by Pentaerythritol tetranitrate reductase. Applied and environmental microbiology , 2864-2868.

Nillius, D., Muller, J., & Muller, N. (2011). Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs. Journal of antimicrobial chemotherapy, 1029-1035.